Abstract
Background: The safety of zopiclone and other Z-drug use has been questioned in many regards. Past issues of side effects, tolerance, abuse, addition, and inappropriate uses have all deserved attention.
Objective: In this paper, the issue of zopiclone safety is again reviewed for information newly arising over the last decade. Method: Information databases were scanned for ‘zopiclone’, and all relevant literature was reviewed. Results: Zopiclone continues to be a very frequently consumed sedative-hypnotic. It is often found in the blood of those with drug abuse, self-harm, overdose, and road accidents. The drug is flourishing as a medication for the elderly, and numerous adverse consequences, including injury, have been associated with it. Zopiclone impairs driving ability, and methods to determine such impairment among active drivers are needed. Conclusion: We have previously suggested that zopiclone prescription and use should have the same concerns as those for benzodiazepine pharmacotherapy. There is evidently no need to change such a stance.Keywords: Zopiclone, risk, safety, side-effects, withdrawal, addiction.
Current Psychopharmacology
Title:Safety with Zopiclone Use: Contemporary Issues
Volume: 6
Author(s): Nevio Cimolai*
Affiliation:
- Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver,Canada
Keywords: Zopiclone, risk, safety, side-effects, withdrawal, addiction.
Abstract: Background: The safety of zopiclone and other Z-drug use has been questioned in many regards. Past issues of side effects, tolerance, abuse, addition, and inappropriate uses have all deserved attention.
Objective: In this paper, the issue of zopiclone safety is again reviewed for information newly arising over the last decade. Method: Information databases were scanned for ‘zopiclone’, and all relevant literature was reviewed. Results: Zopiclone continues to be a very frequently consumed sedative-hypnotic. It is often found in the blood of those with drug abuse, self-harm, overdose, and road accidents. The drug is flourishing as a medication for the elderly, and numerous adverse consequences, including injury, have been associated with it. Zopiclone impairs driving ability, and methods to determine such impairment among active drivers are needed. Conclusion: We have previously suggested that zopiclone prescription and use should have the same concerns as those for benzodiazepine pharmacotherapy. There is evidently no need to change such a stance.Export Options
About this article
Cite this article as:
Cimolai Nevio*, Safety with Zopiclone Use: Contemporary Issues, Current Psychopharmacology 2017; 6 (1) . https://dx.doi.org/10.2174/2211556005666160822112843
DOI https://dx.doi.org/10.2174/2211556005666160822112843 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Impact of Covid-19 on Mental Health: An Overview
Reviews on Recent Clinical Trials Commentary-1 Research Highlights (Never Underestimate the Power of Adenosine in Multiple Sclerosis)
CNS & Neurological Disorders - Drug Targets Psychosomatic Features, Compliance and Complementary Therapies in Rheumatoid Arthritis
Current Rheumatology Reviews Atypical Major Depression - Past, Present, and Future
Current Psychiatry Reviews The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer’s Disease and Parkinson Disease
Current Pharmaceutical Design Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
Current Drug Targets Kinase Inhibitors in Multitargeted Cancer Therapy
Current Medicinal Chemistry Editorial [Hot Topic: Computational Approaches in Medicinal Chemistry and Drug Discovery (Guest Editor: Dr. Fredy Sussman)]
Current Topics in Medicinal Chemistry Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways
Anti-Cancer Agents in Medicinal Chemistry Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Current Drug Targets Pain-Related Behavior and Brain Activation in a Cynomolgus Macaque Model of Postoperative Pain
CNS & Neurological Disorders - Drug Targets Recent Advances in the Assembly of Tri-substituted Oxazoles
Current Organic Chemistry Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets The Use of Human Albumin for the Treatment of Ascites in Patients with Liver Cirrhosis: Item of Safety, Facts, Controversies and Perspectives
Current Drug Safety Mechanism of CNS Drugs and their Combinations for Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry Editorial [Celebrating the Fifth Year Anniversary of Current Alzheimer Research(Guest Editor: Debomoy K. Lahiri)]
Current Alzheimer Research Soft Condensed Matter in Pharmaceutical Design
Current Pharmaceutical Design Advances in Methods for Therapeutic Peptide Discovery, Design and Development
Current Pharmaceutical Biotechnology MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential
Current Genomics Classification of Human Pregnane X Receptor (hPXR) Activators and Non-Activators by Machine Learning Techniques: A Multifaceted Approach
Combinatorial Chemistry & High Throughput Screening